These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36808128)

  • 1. The females have spoken: A patient-centered national survey on the administration of emergent transfusions with the potential for future fetal harm.
    Uhlich R; Hu P; Yazer M; Jansen JO; Patrician P; Marques MB; Reynolds L; Fifolt M; Stephens SW; Gelbard RB; Kerby J; Holcomb JB
    J Trauma Acute Care Surg; 2023 Jun; 94(6):791-797. PubMed ID: 36808128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perception of risk in massive transfusion as it relates to fetal outcomes: A survey of surgeons and nurses at one American trauma center.
    Uhlich R; Hu P; Yazer M; Jansen JO; Patrician P; Reynolds L; Marques MB; Stephens SW; Gelbard RB; Kerby J; Holcomb JB
    Transfusion; 2021 Jul; 61 Suppl 1():S159-S166. PubMed ID: 34269430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes of American adult women toward accepting RhD-mismatched transfusions in bleeding emergencies.
    Yu G; Siegler J; Hayes J; Yazer MH; Spinella PC
    Transfusion; 2022 Aug; 62 Suppl 1():S211-S217. PubMed ID: 35753036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parent perceptions of emergent blood transfusion in children.
    Morgan KM; Lobo R; Annen K; Villarreal RI; Chou S; Uter S; Leonard JC; Dyer C; Yazer M; Spinella PC; Leeper CM
    Transfusion; 2023 May; 63 Suppl 3():S35-S45. PubMed ID: 36971056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
    Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
    Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma.
    Yazer MH; Panko G; Holcomb JB; Kaplan A; Leeper C; Seheult JN; Triulzi DJ; Spinella PC
    Hematology; 2023 Dec; 28(1):2161215. PubMed ID: 36607150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk to future pregnancies of transfusing Rh(D)-negative females of childbearing potential with Rh(D)-positive red blood cells during trauma resuscitation is dependent on their age at transfusion.
    Seheult JN; Stram MN; Pearce T; Bub CB; Emery SP; Kutner J; Watanabe-Okochi N; Sperry JL; Takanashi M; Triulzi DJ; Yazer MH
    Vox Sang; 2021 Aug; 116(7):831-840. PubMed ID: 33491789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the risks of prehospital transfusion of D-positive whole blood to trauma patients who are bleeding in England.
    Cardigan R; Latham T; Weaver A; Yazer M; Green L
    Vox Sang; 2022 May; 117(5):701-707. PubMed ID: 35018634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed feelings about mixed-field agglutination: A pathway for managing females of childbearing potential of unknown RhD-type who are transfused RhD-positive and RhD-negative red blood cells during emergency hemorrhage resuscitation.
    Yazer MH; Gorospe J; Cap AP
    Transfusion; 2021 Jul; 61 Suppl 1():S326-S332. PubMed ID: 34269449
    [No Abstract]   [Full Text] [Related]  

  • 10. Rate of RhD-alloimmunization after the transfusion of RhD-positive red blood cell containing products among injured patients of childbearing age: single center experience and narrative literature review.
    Yazer M; Triulzi D; Sperry J; Corcos A; Seheult J
    Hematology; 2021 Dec; 26(1):321-327. PubMed ID: 33775237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management Considerations for Air Medical Transport Programs Transfusing RhD-Positive Red Blood Cell-Containing Products to Females of Childbearing Potential.
    McCartin MP; Wool GD; Thomas SA; Panfil M; Schoenfeld D; Blumen IJ; Tataris KL; Thomas SH
    Air Med J; 2024; 43(4):348-356. PubMed ID: 38897700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of policies at US hospitals on the selection of RhD type of low-titer O whole blood for use in trauma resuscitation.
    Clayton S; Leeper CM; Yazer MH; Spinella PC
    Transfusion; 2024 May; 64 Suppl 2():S111-S118. PubMed ID: 38501231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical considerations in the use of RhD-positive blood products in trauma.
    Malone JR
    Transfusion; 2024 May; 64 Suppl 2():S4-S10. PubMed ID: 38491917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products.
    Yazer MH; Triulzi DJ; Sperry JL; Seheult JN
    Transfusion; 2021 Jul; 61 Suppl 1():S150-S158. PubMed ID: 34269438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland.
    Susila S; Ilmakunnas M; Lauronen J; Vuorinen P; Ångerman S; Sainio S
    Transfusion; 2024 May; 64 Suppl 2():S119-S125. PubMed ID: 38240146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of severe erythroblastosis fetalis by fetal transfusion: survival of transfused adult erythrocytes in the fetus.
    Pattison N; Roberts A
    Obstet Gynecol; 1989 Dec; 74(6):901-4. PubMed ID: 2586955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for blood transfusion in traumatic and postpartum hemorrhage patients: Analysis of the CRASH-2 and WOMAN trials.
    Kolin DA; Shakur-Still H; Bello A; Chaudhri R; Bates I; Roberts I
    PLoS One; 2020; 15(6):e0233274. PubMed ID: 32492040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the Management of a Pregnant Trauma Patient.
    Jain V; Chari R; Maslovitz S; Farine D; ; Bujold E; Gagnon R; Basso M; Bos H; Brown R; Cooper S; Gouin K; McLeod NL; Menticoglou S; Mundle W; Pylypjuk C; Roggensack A; Sanderson F
    J Obstet Gynaecol Can; 2015 Jun; 37(6):553-74. PubMed ID: 26334607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling the outcomes of different red blood cell transfusion strategies for the treatment of traumatic haemorrhage in the prehospital setting in the United Kingdom.
    Roberts B; Green L; Ahmed V; Latham T; O'Boyle P; Yazer MH; Cardigan R
    Vox Sang; 2022 Nov; 117(11):1287-1295. PubMed ID: 36102164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.